Domov › Rak ledvic (renocelularni karcinom) › Kalifornija › Los Angeles
Klinične študije za Rak ledvic (renocelularni karcinom) v Los Angeles, CA
20 študij za Rak ledvic (renocelularni karcinom) išče udeležence na lokacijah v Los Angeles in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Vključevanje udeležencevFaza 1
- Cedars-Sinai Medical Center, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Vključevanje udeležencevFaza 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Vključevanje udeležencevFaza 1/2
- University of Southern California, Los Angeles
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Vključevanje udeležencevFaza 2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Vključevanje udeležencevFaza 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Vključevanje udeležencevFaza 3
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Vključevanje udeležencevFaza 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
Vključevanje udeležencevFaza 1/2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- The Angeles Clinic and Research Institute, Los Angeles
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Vključevanje udeležencevFaza 3
- USC Norris Comprehensive Cancer Center ( Site 0126), Los Angeles
- Cedars-Sinai Medical Center ( Site 0112), Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Vključevanje udeležencevFaza 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer
Vključevanje udeležencevFaza 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Vključevanje udeležencevFaza 1
- Start Lacn, Los Angeles
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- University of Southern California, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Vključevanje udeležencev
- Oncology Institute for Hope and Innovation, Los Angeles
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Vključevanje udeležencevFaza 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of VET3-TGI in Patients With Solid Tumors
Vključevanje udeležencevFaza 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- UCLA Medical Center, Los Angeles
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Vključevanje udeležencevFaza 3
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles County-USC Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- in še 2
Študije za Rak ledvic (renocelularni karcinom) v drugih mestih
- Houston, TX35 študij
- New York City, NY27 študij
- Nashville, TN23 študij
- Dallas, TX23 študij
- St. Louis, MO23 študij
- Boston, MA16 študij
- Baldwin Park, CA16 študij
- Philadelphia, PA15 študij
- Pittsburgh, PA15 študij
- Queens, NY15 študij
- Rochester, MN14 študij
- Cleveland, OH14 študij
Druge študije v Los Angeles
- Nemalicelični pljučni rak87 študij
- Rak (vse vrste)74 študij
- Rak dojke73 študij
- Rak prostate61 študij
- Kolorektalni rak59 študij
- Metastatski rak57 študij
- Rak jajčnikov50 študij
- Rak pljuč45 študij
- Ploščatocelični karcinom glave in vratu42 študij
- Rak trebušne slinavke35 študij
- Rak endometrija34 študij
- Melanom34 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.